On these specimens (13 mature T-cell neoplasms and 11 controls), a quantitative estimate of percent TRBC1+ events could not be accurately calculated, requiring expert qualitative identification of a monophasic TRBC1 staining pattern to infer clonality (as previously described [20]). The gene discussed is TRBC1; the disease is T-cell and NK-cell neoplasm.